Genocea Stops Pneumonia Vaccine Development After Study Fails
Monday, October 19, 2015
Drug developer Genocea Biosciences Inc said it was suspending the development of a vaccine for pneumonia-causing bacteria after it failed to significantly reduce infection in a mid-stage study.
The company's shares fell 34 percent to $4.75 in premarket trading.
Genocea said it was dropping the development of the vaccine, GEN-004, from its near-term plans to focus on its lead drug – a treatment for genital herpes.
GEN-004 was being developed to fight streptococcus pneumoniae, a type of bacteria that causes a number of infectious diseases including bronchitis, conjunctivitis and brain abscess.
- Health Care